Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
Clinical trial NCT01402284 · COMPLETED
Trial details
- NCT number
- NCT01402284
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-21
- Primary completion
- 2016-07-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.